Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Convergence of neuroinflammation across major neurotropic viral exposomes in AD and ADRD.

Journal of neuroinflammation·2026
Same author

Role of Nanomedicine in Transforming Pharmacotherapy for Substance Use Disorder (SUD).

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2025
Same author

Drug Discovery in the Age of Artificial Intelligence: Transformative Target-Based Approaches.

International journal of molecular sciences·2024
Same author

Convergence of Nanotechnology and Machine Learning: The State of the Art, Challenges, and Perspectives.

International journal of molecular sciences·2024
Same author

Modulation of Paracellular Permeability in SARS-CoV-2 Blood-to-Brain Transcytosis.

Viruses·2024
Same author

Advances in Translational Nanotechnology: Challenges and Opportunities.

Applied sciences (Basel, Switzerland)·2024

Related Experiment Video

Updated: Jun 12, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Immunotherapy for allergies and asthma: present and future.

Shyam S Mohapatra1, Momina Qazi, Gary Hellermann

  • 1Department of Internal Medicine, Division of Allergy and Immunology, University of South Florida College of Medicine, Tampa, FL, USA. smohapat@health.usf.edu

Current Opinion in Pharmacology
|June 25, 2010
PubMed
Summary

Allergen immunotherapy (IT) effectively treats allergic rhinitis and asthma. Recent advancements include established subcutaneous/sublingual methods and novel therapies like anti-IgE antibodies, offering future treatment options.

More Related Videos

Immunofluorescent Labeling in Nasal Mucosa Tissue Sections of Allergic Rhinitis Rats via Multicolor Immunoassay
06:08

Immunofluorescent Labeling in Nasal Mucosa Tissue Sections of Allergic Rhinitis Rats via Multicolor Immunoassay

Published on: September 22, 2023

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Related Experiment Videos

Last Updated: Jun 12, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Immunofluorescent Labeling in Nasal Mucosa Tissue Sections of Allergic Rhinitis Rats via Multicolor Immunoassay
06:08

Immunofluorescent Labeling in Nasal Mucosa Tissue Sections of Allergic Rhinitis Rats via Multicolor Immunoassay

Published on: September 22, 2023

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Area of Science:

  • Immunology
  • Allergy Research
  • Pharmacology

Background:

  • Allergen immunotherapy (IT) has been a recognized treatment for allergic rhinitis and asthma since 1911.
  • Significant advancements in IT have occurred over the last two decades.
  • Current IT practices involve subcutaneous or sublingual allergen administration.

Purpose of the Study:

  • To review recent developments in allergen immunotherapy.
  • To discuss the advantages and disadvantages of both current and experimental IT approaches.
  • To provide insights into emerging non-specific immunotherapies.

Main Methods:

  • Review of established and emerging allergen immunotherapy (IT) approaches.
  • Analysis of subcutaneous and sublingual administration methods.
  • Evaluation of non-specific IT therapies in clinical trials and preclinical research.

Main Results:

  • Established IT methods (subcutaneous, sublingual) are well-researched.
  • Nonspecific IT approaches, including anti-IgE antibodies and soluble IL-4 receptor, are in clinical trials.
  • Experimental IT approaches are in preclinical stages, with potential future clinical application.

Conclusions:

  • Allergen immunotherapy remains a cornerstone for allergic disease treatment.
  • Emerging nonspecific therapies show promise for future clinical use.
  • Ongoing research continues to refine and expand immunotherapy options for allergies.